Article
In vivo emergence of resistance to ceftazidime/avibactam through modification of chromosomal AmpC β-lactamase in Klebsiella aerogenes.
Antimicrobial agents and chemotherapy - 5 Dec 2024
Rodríguez-Pallares Salud, Blanco-Martín Tania, Lence Emilio, Aja-Macaya Pablo, Sánchez-Peña Lucía, González-Pinto Lucía, Rodríguez-Mayo María, Fernández-González Ana, Galán-Sánchez Fátima, Beceiro Alejandro, González-Bello Concepción, Bou Germán, Arca-Suárez Jorge
Abstract excerpt
We describe the in vivo emergence of resistance to ceftazidime/avibactam via modification of AmpC in a clinical Klebsiella aerogenes isolate during therapy with this combination. Paired ceftazidime/avibactam-susceptible/resistant isolates were obtained before and during ceftazidime/avibactam treatment. Whole genome sequencing revealed a differential mutation in AmpC (R148W) in the ceftazidime/avibactam-resistant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
